Free Trial

Scinai Immunotherapeutics (SCNI) Short Interest Ratio & Short Volume

Scinai Immunotherapeutics logo
$1.33 -0.03 (-2.21%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$1.38 +0.04 (+3.38%)
As of 10/3/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Scinai Immunotherapeutics Short Interest Data

Scinai Immunotherapeutics (SCNI) has a short interest of 90,300 shares. This marks a -16.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 90,817 shares to cover all short positions.

Current Short Interest
90,300 shares
Previous Short Interest
108,400 shares
Change Vs. Previous Month
-16.70%
Dollar Volume Sold Short
$147.19 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
1,000,000 shares
Percentage of Shares Shorted
9.03%
Today's Trading Volume
31,927 shares
Average Trading Volume
90,817 shares
Today's Volume Vs. Average
35%
Short Selling Scinai Immunotherapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

SCNI Short Interest Over Time

SCNI Days to Cover Over Time

SCNI Percentage of Float Shorted Over Time

Scinai Immunotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202590,300 shares $147.19 thousand -16.7%N/A0.1 $1.63
8/31/2025108,400 shares $165.85 thousand -53.0%27.7%0.1 $1.53
8/15/2025230,800 shares $366.97 thousand -16.2%N/A0.2 $1.59
7/31/2025275,400 shares $402.08 thousand +869.7%70.4%0.2 $1.46
7/15/202528,400 shares $63.05 thousand -27.0%N/A0.1 $2.22
6/30/202538,900 shares $88.69 thousand -5.8%9.9%0.1 $2.28
6/15/202541,300 shares $91.69 thousand +8,160.0%10.6%0.1 $2.22
5/31/2025500 shares $1.36 thousand +25.0%0.1%0 $2.73
5/15/2025400 shares $1.14 thousand -92.0%0.1%0 $2.85
4/30/20255,000 shares $13.20 thousand +525.0%N/A0.3 $2.64
4/15/2025800 shares $1.54 thousand -57.9%0.2%0.1 $1.92
3/31/20251,900 shares $5.11 thousand -48.7%0.6%0.1 $2.69
3/15/20253,700 shares $12.38 thousand +117.7%1.1%0.3 $3.35
2/28/20251,700 shares $6.02 thousand +88.9%0.5%0.1 $3.54
2/15/2025900 shares $3.01 thousand +125.0%0.3%0.1 $3.34
1/31/2025400 shares $1.42 thousand -86.2%N/A0 $3.55
1/15/20252,900 shares $9.98 thousand +141.7%N/A0.3 $3.44
12/31/20241,200 shares $4.02 thousand -71.4%N/A0.1 $3.35
12/15/20244,200 shares $14.36 thousand -45.5%N/A0.2 $3.42
11/30/20247,700 shares $26.49 thousand +83.3%N/A0.3 $3.44
11/15/20244,200 shares $11.97 thousand +133.3%N/A0.2 $2.85
10/31/20241,800 shares $6.41 thousand -84.8%N/A0.1 $3.56
10/15/202411,800 shares $44.25 thousand -41.6%N/A0.3 $3.75
9/30/202420,200 shares $69.69 thousand +71.2%N/A0 $3.45
9/15/202411,800 shares $40.54 thousand +16.8%N/A0 $3.44
8/31/202410,100 shares $37.67 thousand +62.9%N/A0 $3.73
8/15/20246,200 shares $23.37 thousand -65.6%N/A0 $3.77
7/31/202418,000 shares $83.88 thousand -59.5%N/A0 $4.66
7/15/202444,400 shares $261.52 thousand +114.5%N/A0 $5.89
6/30/202420,700 shares $57.55 thousand +51.1%N/A0 $2.78
6/15/202413,700 shares $47.81 thousand +211.4%N/A0 $3.49
5/31/20244,400 shares $16.50 thousand +633.3%N/A0.2 $3.75
5/15/2024600 shares $2.64 thousand -93.2%N/A0.1 $4.40
4/30/20248,800 shares $4.00 thousand -60.9%N/A0.3 $0.46
4/15/202422,500 shares $10.15 thousand +309.1%N/A0.8 $0.45
3/31/20245,500 shares $2.85 thousand -57.0%N/A0.2 $0.52
3/15/202412,800 shares $6.37 thousand +52.4%N/A0.4 $0.50
2/29/20248,400 shares $4.14 thousand +2.4%N/A0.3 $0.49
2/15/20248,200 shares $4.18 thousand +49.1%N/A0.4 $0.51
1/31/20245,500 shares $2.59 thousand No ChangeN/A0.2 $0.47

SCNI Short Interest - Frequently Asked Questions

What is Scinai Immunotherapeutics' current short interest?

Short interest is the volume of Scinai Immunotherapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 90,300 shares of SCNI short. Learn More on Scinai Immunotherapeutics' current short interest.

Is Scinai Immunotherapeutics' short interest increasing or decreasing?

Scinai Immunotherapeutics saw a decline in short interest in September. As of September 15th, there was short interest totaling 90,300 shares, a decline of 16.7% from the previous total of 108,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Scinai Immunotherapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Scinai Immunotherapeutics: Galecto, Inc. (7.30%), Titan Pharmaceuticals, Inc. (3.74%), Redhill Biopharma Ltd. (1.14%), Pasithea Therapeutics Corp. (0.82%), GRI Bio, Inc. (18.77%), Oragenics, Inc. (2.86%), Calidi Biotherapeutics, Inc. (8.74%), Xenetic Biosciences, Inc. (1.88%), NKGen Biotech, Inc. (1.67%), Aditxt, Inc. (1.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Scinai Immunotherapeutics stock?

Short selling SCNI is an investing strategy that aims to generate trading profit from Scinai Immunotherapeutics as its price is falling. SCNI shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Scinai Immunotherapeutics?

A short squeeze for Scinai Immunotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SCNI, which in turn drives the price of the stock up even further.

How often is Scinai Immunotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCNI, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:SCNI) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners